Skip to main content

and
  1. Article

    Open Access

    Intraoperative strategies and techniques to achieve surgical radicality in pancreatic cancer

    The treatment of pancreatic cancer presents a challenging task in surgical oncology, demanding innovative approaches to achieve radical resection and improve patient outcomes. This article provides an overview...

    Thomas Hank, Carl-Stephan Leonhardt, Ulla Klaiber, Oliver Strobel MD in European Surgery (2024)

  2. Article

    Open Access

    Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy

    Pancreatic ductal adenocarcinoma (PDAC) is projected to be the second leading cause of cancer mortality by 2030. Bulk transcriptomic analyses have distinguished ‘classical’ from ‘basal-like’ tumors with more a...

    Teresa G. Krieger, Solange Le Blanc, Julia Jabs, Foo Wei Ten in Nature Communications (2021)

  3. No Access

    Article

    Neoadjuvant and adjuvant chemotherapy in pancreatic cancer

    Only 15–20% of patients with pancreatic ductal adenocarcinoma (PDAC) have a resectable tumor at the time of diagnosis. Effective multimodal treatment concepts including neoadjuvant chemotherapy are therefore n...

    Ulla Klaiber, Carl-Stephan Leonhardt, Oliver Strobel in Langenbeck's Archives of Surgery (2018)